Literature DB >> 21136661

Salivary biomarkers associated with perceived satiety and body mass in humans.

Lucien F Harthoorn1, Raymond G Schipper, Arnoud Loof, Pieter F G Vereijken, Waander L Van Heerde, Eric Dransfield.   

Abstract

Regulation of food intake and energy homeostasis is controlled by a delicate balancing of numerous central and peripheral factors, including circulating peptide hormones. This study investigated the proteome of saliva using SELDI-TOF-MS in relation to satiety and body mass index (BMI) in humans. Within a longitudinal test session, 18 subjects were exposed to a lunch-induced hunger-satiety shift, while every 15 min collecting their whole saliva and rating their hunger and satiety. Saliva was analysed by SELDI-TOF-MS using IMAC arrays with a chromatographic copper surface (IMAC-Cu). From all subjects and time points measured, peptide and protein profiles showed 190 common peaks. Their interrelationships show that 37% of the variation was accounted for in one dimension. About 30 means had a strong association (0.70<|r|<0.95) with all subjective satiety ratings across time during the test session, and seven peaks were significantly correlated to BMI. Database MS searches indicated characterisation of some relevant metabolic peptide hormones. In conclusion, SELDI-TOF-MS on human saliva provides a valuable and noninvasive way of profiling that enables characterisation of novel and differently expressed peptides and proteins which can be used as biomarkers of satiety and overweight.
Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2007        PMID: 21136661     DOI: 10.1002/prca.200700448

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  1 in total

1.  Novel possibilities in the study of the salivary proteomic profile using SELDI-TOF/MS technology.

Authors:  Fatima Ardito; Donatella Perrone; Roberto Cocchi; Lucio Lo Russo; Alfredo DE Lillo; Giovanni Giannatempo; Lorenzo Lo Muzio
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.